Steven J Hatfill, a virologist known for supporting hydroxychloroquine as a treatment for Covid-19, has been appointed to a significant role at the Department of Health and Human Services. While during Trump's presidency, Hatfill advocated for hydroxychloroquine despite minimal evidence of efficacy and serious safety concerns, including heart rhythm issues that led the FDA to issue warnings. Now, he will focus on enhancing pandemic preparedness and scientific understanding of various global diseases, while defending hydroxychloroquine's safety due to its use in treating other conditions like lupus and rheumatoid arthritis.
In June 2020, just months after the pandemic started, the FDA warned against using hydroxychloroquine and chloroquine to treat Covid-19 over reports of serious heart rhythm problems.
During his appointment, Hatfill aims to prepare the nation for future pandemics and enhance scientific awareness across a variety of global diseases.
Hatfill defended hydroxychloroquine as a safe drug, emphasizing its established use for other ailments despite the controversial stance surrounding its use against Covid-19.
The Trump administration endorsed hydroxychloroquine as a Covid-19 treatment, despite warnings from health authorities about its efficacy and potential side effects.
Collection
[
|
...
]